H. Dimant

Modulation effect of filamentous phage on alpha-synuclein aggregation.

B. Solomon, Noa Sharon, H. Dimant, 2009, Biochemical and biophysical research communications.

Exosome-associated AAV vector as a robust and convenient neuroscience tool

B. Hyman, T. Ragan, E. Hudry, 2016, Gene Therapy.

Direct Visualization of CHIP-Mediated Degradation of Alpha-Synuclein In Vivo: Implications for PD Therapeutics

B. Hyman, P. McLean, Z. Fan, 2014, PloS one.

Molecular Chaperones and Co-Chaperones in Parkinson Disease

P. McLean, D. Ebrahimi-Fakhari, H. Dimant, 2012, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

Chronic Treatment with Novel Small Molecule Hsp90 Inhibitors Rescues Striatal Dopamine Levels but Not α-Synuclein-Induced Neuronal Cell Loss

Nikolaus R. McFarland, P. McLean, Z. Fan, 2014, PloS one.

Exosome-associated AAV vector as a robust and convenient neuroscience tool

B. Hyman, T. Ragan, E. Hudry, 2016, Gene Therapy.

Exosome-associated AAV vector as a robust and convenient neuroscience tool

B. Hyman, T. Ragan, E. Hudry, 2016, Gene Therapy.

Filamentous Phages Reduce α-Synuclein Oligomerization in the Membrane Fraction of SH-SY5Y Cells

B. Solomon, H. Dimant, 2010, Neurodegenerative Diseases.

TAR1, A Human Anti-p53 Single-Chain Antibody, Restores Tumor Suppressor Function to Mutant p53 Variants

S. Orgad, B. Solomon, I. Benhar, 2010, Journal of immunotherapy.

Direct detection of alpha synuclein oligomers in vivo

Nikolaus R. McFarland, Suneil K. Kalia, B. Hyman, 2013, Acta neuropathologica communications.

Brain pharmacology of intrathecal antisense oligonucleotides revealed through multimodal imaging.

Mohammed Q. Qutaish, Jenna M. Sullivan, Marc E. Seaman, 2019, JCI insight.